Shopping Cart 0
Cart Subtotal
AED 0

Generics Global Group of Eight (G8) Industry Guide 2013-2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 5487

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 10973

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 16460
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Generics Global Group of Eight (G8) Industry Guide 2013-2022

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:

- What was the size of the G8 generics market by value in 2017?

- What will be the size of the G8 generics market in 2022?

- What factors are affecting the strength of competition in the G8 generics market?

- How has the market performed over the last five years?

- How large is the G8 generics market in relation to its regional counterparts?

Scope

Essential resource for top-line data and analysis covering the G8 generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

- The G8 countries contributed USD 1,75,638.2 million in 2017 to the global generics industry, with a compound annual growth rate (CAGR) of 7.3% between 2013 and 2017. The G8 countries are expected to reach a value of USD 2,25,943.9 million in 2022, with a CAGR of 5.2% over the 2017-22 period.

- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of USD 1,02,919.9 million in 2017. This was followed by Japan and Germany, with a value of USD 25,218.0 and USD 17,343.3 million, respectively.

- The US is expected to lead the generics industry in the G8 nations with a value of USD 1,30,127.0 million in 2016, followed by Japan and Germany with expected values of USD 33,841.0 and USD 19,577.2 million, respectively.

Reasons to buy

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market

- Leading company profiles reveal details of key generics market players' G8 operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume

- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

READ MORE

Table Of Content

Scope

Table of Contents

Introduction 14

What is this report about? 14

Who is the target reader? 14

How to use this report 14

Definitions 14

Group of Eight (G8) Generics 15

Industry Outlook 15

Generics in Canada 19

Market Overview 19

Market Data 20

Market Segmentation 22

Market outlook 23

Five forces analysis 25

Macroeconomic indicators 32

Generics in France 34

Market Overview 34

Market Data 35

Market Segmentation 37

Market outlook 38

Five forces analysis 40

Macroeconomic indicators 46

Generics in Germany 48

Market Overview 48

Market Data 49

Market Segmentation 51

Market outlook 52

Five forces analysis 54

Macroeconomic indicators 60

Generics in Italy 62

Market Overview 62

Market Data 63

Market Segmentation 65

Market outlook 66

Five forces analysis 68

Macroeconomic indicators 74

Generics in Japan 76

Market Overview 76

Market Data 77

Market Segmentation 79

Market outlook 80

Five forces analysis 82

Macroeconomic indicators 88

Generics in Russia 90

Market Overview 90

Market Data 91

Market Segmentation 93

Market outlook 94

Five forces analysis 96

Macroeconomic indicators 102

Generics in The United Kingdom 104

Market Overview 104

Market Data 105

Market Segmentation 107

Market outlook 108

Five forces analysis 110

Macroeconomic indicators 117

Generics in The Unite

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

MarketLine, Pharmaceuticals and Healthcare, Generics , G8

Generics Global Group of Eight (G8) Industry Guide 2013-2022

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:

- What was the size of the G8 generics market by value in 2017?

- What will be the size of the G8 generics market in 2022?

- What factors are affecting the strength of competition in the G8 generics market?

- How has the market performed over the last five years?

- How large is the G8 generics market in relation to its regional counterparts?

Scope

Essential resource for top-line data and analysis covering the G8 generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

- The G8 countries contributed USD 1,75,638.2 million in 2017 to the global generics industry, with a compound annual growth rate (CAGR) of 7.3% between 2013 and 2017. The G8 countries are expected to reach a value of USD 2,25,943.9 million in 2022, with a CAGR of 5.2% over the 2017-22 period.

- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of USD 1,02,919.9 million in 2017. This was followed by Japan and Germany, with a value of USD 25,218.0 and USD 17,343.3 million, respectively.

- The US is expected to lead the generics industry in the G8 nations with a value of USD 1,30,127.0 million in 2016, followed by Japan and Germany with expected values of USD 33,841.0 and USD 19,577.2 million, respectively.

Reasons to buy

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market

- Leading company profiles reveal details of key generics market players' G8 operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume

- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

READ MORE

Scope

Table of Contents

Introduction 14

What is this report about? 14

Who is the target reader? 14

How to use this report 14

Definitions 14

Group of Eight (G8) Generics 15

Industry Outlook 15

Generics in Canada 19

Market Overview 19

Market Data 20

Market Segmentation 22

Market outlook 23

Five forces analysis 25

Macroeconomic indicators 32

Generics in France 34

Market Overview 34

Market Data 35

Market Segmentation 37

Market outlook 38

Five forces analysis 40

Macroeconomic indicators 46

Generics in Germany 48

Market Overview 48

Market Data 49

Market Segmentation 51

Market outlook 52

Five forces analysis 54

Macroeconomic indicators 60

Generics in Italy 62

Market Overview 62

Market Data 63

Market Segmentation 65

Market outlook 66

Five forces analysis 68

Macroeconomic indicators 74

Generics in Japan 76

Market Overview 76

Market Data 77

Market Segmentation 79

Market outlook 80

Five forces analysis 82

Macroeconomic indicators 88

Generics in Russia 90

Market Overview 90

Market Data 91

Market Segmentation 93

Market outlook 94

Five forces analysis 96

Macroeconomic indicators 102

Generics in The United Kingdom 104

Market Overview 104

Market Data 105

Market Segmentation 107

Market outlook 108

Five forces analysis 110

Macroeconomic indicators 117

Generics in The Unite

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

MarketLine, Pharmaceuticals and Healthcare, Generics , G8